Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,048 papers from all fields of science
Search
Sign In
Create Free Account
esaprazole
Known as:
N-((N-cyclohexylcarbamoyl)methyl)piperazine
, hexaprazol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Piperazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Inhibitory cholinergic effects of esaprazole on gastric secretion and plasma gastrin levels in the dog.
C. Blandizzi
,
G. Mengozzi
,
L. Intorre
,
G. Natale
,
G. Soldani
,
M. del Tacca
Pharmacology
1993
Corpus ID: 3273893
The effects of esaprazole, a novel antiulcer drug, on gastric acid secretion and plasma gastrin levels were investigated in dogs…
Expand
1993
1993
Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
P. D. Dal Santo
,
F. Vianello
,
+7 authors
F. Di Mario
Zeitschrift für Gastroenterologie - German…
1993
Corpus ID: 30159516
To study the effect of Esaprazole, a new antiulcer drug, on acid, peptic and alkaline secretion a modified gastric acid test was…
Expand
1992
1992
Gastric antisecretory effects of esaprazole in rats.
C. Blandizzi
,
G. Natale
,
M. De Bona
,
M. del Tacca
Digestion
1992
Corpus ID: 23993492
The effects of esaprazole on gastric secretion (volume, pepsin and acid output) were investigated on animal models, both in vivo…
Expand
1989
1989
Gastrointestinal hormones and serum group I pepsinogen after intravenous hexaprazol injection in healthy volunteers
F. Vianello
,
P. D. Santo
,
+7 authors
R. Naccarato
1989
Corpus ID: 57106483
Thirteen healthy control subjects were studied in order to evaluate any effect of acute hexaprazol injection on some…
Expand
1987
1987
Esaprazole in the treatment of gastric ulcer: preliminary clinical trial.
P. D. dal Monte
,
S. Gullini
,
A. Saggioro
,
L. Beinat
,
C. Castiglioni
Drugs under experimental and clinical research
1987
Corpus ID: 8118449
The activity and tolerability of esaprazole administered once a day at doses of 900 and 1350 mg/day in the treatment of gastric…
Expand
1987
1987
Effect of esaprazole on sham-feeding-stimulated and pentagastrin-stimulated acid secretion in humans
M. Lazzaroni
,
O. Sangaletti
,
C. Ghirardosi
,
S. Ardizzone
,
G. Porro
1987
Corpus ID: 78507197
1986
1986
Quantitation of hexaprazol in human plasma and urine by capillary gas chromatography with nitrogen-sensitive detection.
M. Girometta
,
L. Loschi
,
P. Ventura
Journal of Chromatography A
1986
Corpus ID: 12497876
1986
1986
Effect of Esaprazole on Gastric Mucosal Potential Difference after Oral Administration of Aspirin (ASA)
S. Ardizzone
,
O. Sangaletti
,
C. Ghirardosi
,
G. Porro
Journal of International Medical Research
1986
Corpus ID: 31950208
The potential protective properties of esaprazole on the gastric mucosa following administration of aspirin were evaluated by…
Expand
1985
1985
Hexaprazol antagonism to gastric electrical potential fall by acetylsalicylic acid in rat.
B. Lumachi
,
R. Scuri
Drugs under experimental and clinical research
1985
Corpus ID: 467359
Hexaprazol was tested against the gastric barrier breaking effect of aspirin (ASA), using the electric potential difference (PD…
Expand
1984
1984
Hexaprazol: a new antiulcer drug with a cytoprotective action.
R. Scuri
,
G. Mondani
,
P. Fantini
,
V. Dàlla Valle
,
B. Valsecchi
Bollettino chimico farmaceutico
1984
Corpus ID: 44754354
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE